Dobson R et al (2019) Multiple sclerosis—a review. Eur J Neurol 26(1):27–40
Article CAS PubMed Google Scholar
Simone IL et al (2000) Early onset multiple sclerosis. Neurol Sci 21(4 Suppl 2):S861-863
Article CAS PubMed Google Scholar
Reich DS et al (2018) Multiple sclerosis. N Engl J Med 378(2):169–180
Article CAS PubMed PubMed Central Google Scholar
Compston A et al (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
Article CAS PubMed Google Scholar
Ambrose AF et al (2013) Risk factors for falls among older adults: a review of the literature. Maturitas 75(1):51–61
Berry SD et al (2019) Hip fractures in older adults in 2019. JAMA 321(22):2231–2232
Article PubMed PubMed Central Google Scholar
Akkawi I et al (2018) Osteoporosis: current concepts. Joints 6(2):122–127
Article PubMed PubMed Central Google Scholar
Prevention and management of osteoporosis: report of a WHO scientific group (2020) WHO technical report series; 921. World Health Organisation, Geneva, Switzerland
The Royal Australian College of General Practitioners and Osteoporosis Australia (2017) Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. 2nd edn. East Melbourne, Victoria, Australia
Ebeling PR, Seeman E, Center J, Chen W, Chiang C, Diamond T, Duque G, Eisman JA, Elliot J, Ganda K, Jesudason D, Jones G, Lyubomirsky G, Major G, Marabani M, March L, Prince RL, Seibel MJ, Stuckey B, Sztal-Mazer S, Stanton S, Waters J, White C (2021) Healthy Bones Australia. Position Statement on the Management of Osteoporosis. https://healthybonesaustralia.org.au/wp-content/uploads/2023/01/position-statement-on-osteoporosis-dec-2022.pdf
Nowson CA et al (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 196(11):686–687
Wong RMY et al (2020) The effectiveness of exercises on fall and fracture prevention amongst community elderlies: a systematic review and meta-analysis. J Orthop Translat 24:58–65
Article CAS PubMed PubMed Central Google Scholar
Bazelier MT et al (2012) Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler 18(5):622–627
Bazelier MT et al (2011) The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res 26(9):2271–2279
Dobson R et al (2012) Bone health and multiple sclerosis. Mult Scler 18(11):1522–1528
Azadvari M et al (2022) The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci. https://doi.org/10.1007/s10072-022-05871-w
Moen SM et al (2011) Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology 77(2):151–157
Article CAS PubMed Google Scholar
Zinganell A et al (2023) Screening for osteoporosis in people with MS: a new risk score. Mult Scler Relat Disord 74:104726
Wade SW et al (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182
Article CAS PubMed Google Scholar
Pilutti LA et al (2019) Body composition and disability in people with multiple sclerosis: a dual-energy x-ray absorptiometry study. Mult Scler Relat Disord 29:41–47
Weinstock-Guttman B et al (2004) Risk of bone loss in men with multiple sclerosis. Mult Scler 10(2):170–175
Nieves J et al (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44(9):1687–1692
Article CAS PubMed Google Scholar
Cosman F et al (1998) Fracture history and bone loss in patients with MS. Neurology 51(4):1161–1165
Article CAS PubMed Google Scholar
Edwards T et al (2017) The effect of exercise training in adults with multiple sclerosis with severe mobility disability: a systematic review and future research directions. Mult Scler Relat Disord 16:31–39
Sosnoff JJ et al (2011) Mobility, balance and falls in persons with multiple sclerosis. PLoS ONE 6(11):e28021
Article CAS PubMed PubMed Central Google Scholar
Matsuda PN et al (2011) Falls in multiple sclerosis. PM R 3(7):624–632; quiz 632
Jacobs BM et al (2020) BMI and low vitamin D are causal factors for multiple sclerosis: a Mendelian randomization study. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000662
Article PubMed PubMed Central Google Scholar
Kanis JA et al (2009) FRAX and its applications to clinical practice. Bone 44(5):734–743
Bisson EJ et al (2019) Accuracy of FRAX((R)) in people with multiple sclerosis. J Bone Miner Res 34(6):1095–1100
Article CAS PubMed Google Scholar
Brouwers MC et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):E839-842
Article PubMed PubMed Central Google Scholar
Hearn AP et al (2010) Osteoporosis in multiple sclerosis. Mult Scler 16(9):1031–1043
Scottish Intercollegiate Guidelines Network (SIGN) (2021) Management of osteoporosis and the prevention of fragility fractures. SIGN publication no. 142. Edinburgh, Scotland
National Institute for Health and Care Excellence (NICE) (2014) Multiple sclerosis in adults: management. Clinical guideline. https://www.nice.org.uk/guidance/ng220/resources/multiple-sclerosis-in-adults-management-pdf-66143828948677
Multiple Sclerosis Society of Canada (2018) Vitamin D and multiple sclerosis recommendations, Canada. https://mscanada.ca/sites/default/files/documents/2023-04/Vitamin%20D%20Recommendations%20-%20HCPs%20ENG.pdf
Olek MJ et al (2022) Treatment of acute exacerbations of multiple sclerosis in adults. UpToDate®
Aspray TJ et al (2014) National osteoporosis society vitamin D guideline summary. Age Ageing 43(5):592–595
NICE Guideline (2012) Osteoporosis: assessing the risk of fragility fracture. Clinical guideline. UK. www.nice.org.uk/guidance/cg146
Kurtzke JFMD (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
Article CAS PubMed Google Scholar
Heffernan MP et al (2006) Prevention of osteoporosis associated with chronic glucocorticoid therapy. JAMA 295(11):1300–1303
Article CAS PubMed Google Scholar
Adami G et al (2019) Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int 30(6):1145–1156
Article CAS PubMed Google Scholar
Buckley L et al (2017) 2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 69(8):1521–1537
Boeschoten RE et al (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341
Mirmosayyeb O et al (2021) Prevalence of seizure/epilepsy in patients with multiple sclerosis: a systematic review and meta-analysis. Int J Prev Med 12:14
PubMed PubMed Central Google Scholar
Motl RW et al (2005) Physical activity and multiple sclerosis: a meta-analysis. Mult Scler (Houndmills, Basingstoke, England) 11(4):459–463
Cetin K et al (2007) Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample. Mult Scler 13(8):1046–1053
Article CAS PubMed Google Scholar
Australian Bureau of Statistics (2016) Patterns of use of mental health services and prescription medications, 2011. https://www.abs.gov.au/ausstats/abs@.nsf/mf/4329.0.00.003
Windt R et al (2013) Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients. Int J Clin Pharm 35(6):1229–1235
Article CAS PubMed Google Scholar
Huang Z et al (2015) BMI levels with MS Bone mineral density levels in adults with multiple sclerosis: a meta-analysis. Int J Neurosci 125(12):904–912
Comments (0)